Gene · 57733
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer's disease risk. | Mol Psychiatry | 2023 | 37666928 | PubTator, text mining | PubMed |
| Tumor cell-derived exosomes regulate macrophage polarization: Emerging directions in the study of tumor genesis and development. | Heliyon | 2023 | 37662730 | PubTator, text mining | PubMed |
| Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases. | Chem Sci | 2023 | 37655021 | PubTator, text mining | PubMed |
| Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function. | Cancer Immunol Res | 2023 | 37649085 | PubTator, text mining | PubMed |
| Combination of deep XLMS with deep learning reveals an ordered rearrangement and assembly of a major protein component of the vaccinia virion. | mBio | 2023 | 37646531 | PubTator, text mining | PubMed |
| Improving the Therapeutic Potential of G-CSF through Compact Circular PEGylation Based on Orthogonal Conjugations. | Biomacromolecules | 2023 | 37638739 | PubTator, text mining | PubMed |
| Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using Tetrahymena group I intron ribozyme. | Mol Ther Nucleic Acids | 2023 | 37637208 | PubTator, text mining | PubMed |
| A global view of the human post-translational modification landscape. | Biochem J | 2023 | 37610048 | PubTator, text mining | PubMed |
| Gut ecological networks reveal associations between bacteria, exercise, and clinical profile in non-alcoholic fatty liver disease patients. | mSystems | 2023 | 37606372 | PubTator, text mining | PubMed |
| A new perspective on HIV: effects of HIV on brain-heart axis. | Front Cardiovasc Med | 2023 | 37600062 | PubTator, text mining | PubMed |
| Klotho: A new therapeutic target in diabetic retinopathy? | World J Diabetes | 2023 | 37547589 | PubTator, text mining | PubMed |
| Human Post-Translational SUMOylation Modification of SARS-CoV-2 Nucleocapsid Protein Enhances Its Interaction Affinity with Itself and Plays a Critical Role in Its Nuclear Translocation. | Viruses | 2023 | 37515286 | PubTator, text mining | PubMed |
| Administration of mRNA-Nanomedicine-Augmented Calvarial Defect Healing via Endochondral Ossification. | Pharmaceutics | 2023 | 37514151 | PubTator, text mining | PubMed |
| Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review. | Diagnostics (Basel) | 2023 | 37510072 | PubTator, text mining | PubMed |
| High Density of N- and O-Glycosylation Shields and Defines the Structural Dynamics of the Intrinsically Disordered Ectodomain of Receptor-type Protein Tyrosine Phosphatase Alpha. | JACS Au | 2023 | 37502146 | PubTator, text mining | PubMed |
| Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3' untranslated region. | Front Cell Dev Biol | 2023 | 37484909 | PubTator, text mining | PubMed |
| Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry. | Nat Commun | 2023 | 37474505 | PubTator, text mining | PubMed |
| Mammalian neurotoxins, Blarina paralytic peptides, cause hyperpolarization of human T-type Ca channel hCav3.2 activation. | J Biol Chem | 2023 | 37468103 | PubTator, text mining | PubMed |
| Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase. | J Vis Exp | 2023 | 37458468 | PubTator, text mining | PubMed |
| Small Open Reading Frame-Encoded Micro-Peptides: An Emerging Protein World. | Int J Mol Sci | 2023 | 37445739 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57733/papers?page=7